0001437749-22-019667.txt : 20220809
0001437749-22-019667.hdr.sgml : 20220809
20220809190047
ACCESSION NUMBER: 0001437749-22-019667
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220807
FILED AS OF DATE: 20220809
DATE AS OF CHANGE: 20220809
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kelderman Kim
CENTRAL INDEX KEY: 0001739054
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-17272
FILM NUMBER: 221149920
MAIL ADDRESS:
STREET 1: 614 MCKINLEY PLACE NE
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55413
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIO-TECHNE Corp
CENTRAL INDEX KEY: 0000842023
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 411427402
STATE OF INCORPORATION: MN
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 614 MCKINLEY PL N E
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55413
BUSINESS PHONE: 6123798854
MAIL ADDRESS:
STREET 1: 614 MCKINLEY PLACE NE
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55413
FORMER COMPANY:
FORMER CONFORMED NAME: TECHNE CORP /MN/
DATE OF NAME CHANGE: 19920703
4
1
rdgdoc.xml
FORM 4
X0306
4
2022-08-07
0000842023
BIO-TECHNE Corp
TECH
0001739054
Kelderman Kim
614 MCKINLEY PLACE NE
MINNEAPOLIS
MN
55413
1
Pres. Diagnostics & Genom
Common Stock
2022-08-07
4
M
0
2363
0
A
4352
D
Common Stock
2022-08-07
4
F
0
1214
382.97
D
3138
D
Stock Option (Right to Buy)
150.7800
2025-05-01
Common Stock
7511
7511
D
Stock Option (Right to Buy)
177.3200
2025-08-08
Common Stock
12044
12044
D
Stock Option (Right to Buy)
177.3200
2025-08-08
Common Stock
9033
9033
D
Restricted Stock Units
2022-08-07
4
M
0
2363
0
D
Common Stock
2363
0
D
Stock Option (Right to Buy)
190.4100
2026-08-07
Common Stock
11961
11961
D
Stock Option (Right to Buy)
190.4100
2026-08-07
Common Stock
15948
15948
D
Restricted Stock Units
Common Stock
2015
2015
D
Stock Option (Right to Buy)
267.8700
2027-08-05
Common Stock
8991
8991
D
Stock Option (Right to Buy)
267.8700
2027-08-05
Common Stock
11988
11988
D
Stock Option (Right to Buy)
267.8700
2027-08-05
Common Stock
8325
8325
D
Stock Option (Right to Buy)
267.8700
2027-08-05
Common Stock
8325
8325
D
Restricted Stock Units
Common Stock
1245
1245
D
Stock Option (Right to Buy)
481.8200
2028-08-06
Common stock
6486
6486
D
Stock Option (Right to Buy)
481.8200
2028-08-06
Common Stock
4864
4864
D
Fully exercisable.
Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
On 8/7/2022, the Board of Directors certified vesting of 2,363 performance RSUs.
Options to purchase 3,987 shares vest on each of 8/7/2020, 8/7/2021, 8/7/2022 and 8/7/2023.
Vests in full or in part on 8/5/2023 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
Options to purchase 2,997 shares vest on each of 8/5/2021, 8/5/2022, 8/5/2023 and 8/5/2024.
Options to purchase 2,775 shares vest on each of 8/5/2021, 8/5/2022 and 8/5/2023.
Vests in full on the date performance of certain product revenue goals during the period of fiscal 2021-2023 is certified by the Administrator, in no event earlier than 8/5/2021.
Vests in full or in part on 8/6/2024 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
Options to purchase 1,621 shares vest on each of 8/6/2022 and 8/6/2023 and options to purchase 1,622 shares vest on each of 8/6/2024 and 8/6/2025.
/s/ Brenda S. Furlow as Attorney-in-Fact for Kim Kelderman pursuant to Power of Attorney previously filed.
2022-08-09